New tool offers personalized approach to blood cancer care

Researchers have developed a new tool to help clinicians tailor personalized treatment plans for patients with a rare blood cancer called chronic myelomonocytic leukemia (CMML). The tool, called the international CMML Prognostic Scoring System (iCPSS), may help improve a patient’s chance of survival.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup